Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-12-29
pubmed:abstractText
Fibrin plays a vital structural role in thrombus integrity. Thus, the ability to assess fibrin architecture has a potential to provide insight into thrombosis and thrombolysis. Fibrin has an anisotropic molecular structure, which enables it to be seen with polarized light. Therefore, we aimed to determine if automated polarized light microscopy methods of quantifying two structural parameters; fibrin fiber bundle orientation and fibrin's optical retardation (OR: a measure of molecular anisotropy) could be used to assess thrombi. To compare fibrin fiber bundle orientation we analyzed picrosirius red-stained sections obtained from clots formed: (A) in vitro, (B) in injured and stenotic coronary arteries, and (C) in surgically created aortic aneurysms (n=6 for each group). To assess potential changes in OR, we examined fibrin in picrosirius red-stained clots formed after ischemic preconditioning (10 min ischemia+10 min reflow; a circumstance shown to enhance lysability) and in control clots (n=8 each group). The degree of fibrin organization differed significantly according to the location of clot formation; fibrin was most aligned in the aneurysms and least aligned in vitro whereas fibrin in the coronary clots had an intermediate organization. The OR of fibrin in the clots formed after ischemic preconditioning was lower than that in controls (2.9+/-0.5 nm versus 5.4+/-1.0 nm, P<0.05). The automated polarized light analysis methods not only enabled fibrin architecture to be assessed, but also revealed structural differences in clots formed under different circumstances.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-10545379, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-10695490, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-10764803, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-10807754, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-10880420, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-11074507, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-12130481, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-12370216, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-12642590, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-15217804, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-15351844, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-15465869, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16091450, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16230484, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16409460, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16458148, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16488165, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16534030, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16793123, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16888133, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-16995902, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-17208341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-17333457, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-17414213, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-17768694, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-18278173, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-2027329, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-2705508, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-2750655, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-3566985, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-4129194, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-4940003, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-7535519, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-7691261, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-8537959, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-9337221, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-9495306, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-9746538, http://linkedlifedata.com/resource/pubmed/commentcorrection/19054699-9880336
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1096-0961
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
51-6
pubmed:dateRevised
2010-9-22
pubmed:meshHeading
pubmed:articleTitle
Fibrin architecture in clots: a quantitative polarized light microscopy analysis.
pubmed:affiliation
Cardiovascular Research Institute, Department of Emergency Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA. peter.whittaker@wayne.edu
pubmed:publicationType
Journal Article, Evaluation Studies, Research Support, N.I.H., Extramural